Elanco/ELAN
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX
About Elanco
Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company's operations are conducted globally and sell its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production. The company's product portfolio of approximately 200 brands.
Ticker
ELAN
Sector
Healthcare
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Greenfield, United States
Employees
9,550
Website
www.elanco.com
Elanco Metrics
BasicAdvanced
$6.9B
Market cap
-
P/E ratio
-$2.65
EPS
1.34
Beta
-
Dividend rate
Price and volume
Market cap
$6.9B
Beta
1.34
Financial strength
Current ratio
3.287
Quick ratio
1.683
Long term debt to equity
94.567
Total debt to equity
95.195
Interest coverage (TTM)
0.88%
Management effectiveness
Return on assets (TTM)
1.03%
Return on equity (TTM)
-19.24%
Valuation
Price to revenue (TTM)
1.58
Price to book
1.14
Price to tangible book (TTM)
-2.64
Price to free cash flow (TTM)
24.84
Growth
Revenue change (TTM)
-1.73%
Earnings per share change (TTM)
4,879.10%
3-year revenue growth
4.21%
3-year earnings per share growth
28.83%
What the Analysts think about Elanco
Analyst Ratings
Majority rating from 15 analysts.
Elanco Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.2B
16.43%
Net income
$32M
-122.70%
Profit margin
2.65%
-119.46%
Elanco Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.18
$0.18
$0.08
$0.34
-
Expected
$0.05
$0.12
$0.11
$0.26
$0.24
Surprise
276.74%
51.40%
-24.53%
28.93%
-
Elanco News
AllArticlesVideos
An Investigation Has Commenced on Behalf of Elanco Animal Health Incorporated Shareholders. Contact Levi & Korsinsky to Discuss your ELAN Losses.
Accesswire·12 hours ago
ELAN INVESTIGATION REMINDER: Elanco (NYSE:ELAN) Investors that Suffered Losses are Encouraged to Contact BFA Law about Securities Fraud Investigation
Accesswire·13 hours ago
Elanco Animal Health Incorporated INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Elanco (ELAN)
Accesswire·21 hours ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Elanco stock?
Elanco (ELAN) has a market cap of $6.9B as of July 04, 2024.
What is the P/E ratio for Elanco stock?
The price to earnings (P/E) ratio for Elanco (ELAN) stock is 0 as of July 04, 2024.
Does Elanco stock pay dividends?
No, Elanco (ELAN) stock does not pay dividends to its shareholders as of July 04, 2024.
When is the next Elanco dividend payment date?
Elanco (ELAN) stock does not pay dividends to its shareholders.
What is the beta indicator for Elanco?
Elanco (ELAN) has a beta rating of 1.34. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Elanco stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.